CADRENAL THERAPEUTICS INC (CVKD) Stock Income Statement
NASDAQ:CVKD - Nasdaq - US1276362076 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 10.96M | 7.63M | 2.70M | N/A | |||
| Research and Development | 4.21M | 4.08M | 390.00K | N/A | |||
| Selling, General, and Administrative Expenses | 6.75M | 3.55M | 2.31M | N/A | |||
| Operating Income | -10.96M | -7.63M | -2.70M | 0.00 | |||
| Interest Income/Expense | 309.30K | 15.90K | -4.01M | N/A | |||
| Non Recurring Items | 0.00 | -740.10K | N/A | N/A | |||
| Income Before Taxes | -10.65M | -8.36M | -6.71M | N/A | |||
| Income Tax | N/A | N/A | 0.00 | N/A | |||
| Net Income | -10.65M | -8.36M | -6.71M | N/A | |||
| EBITDA | -10.96M | -7.63M | N/A | N/A | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -8.73 | -9.29 | -0.85 | N/A | |||
| Non GAAP EPS | -8.67 | N/A | N/A | N/A | |||
| Statistics | |||||||
All data in USD